Europe's medicines regulator has recommended the suspension of generic drug approvals due to "unreliable" tests conducted by an Indian firm. » Read More
Get the best of CNBC in your inbox
Stephen Davies, CEO of Javelin Wealth Management, says European markets could prove more attractive than the U.S. reflation trade.
Sophia Yan takes a look at the competition between the biggest bike-sharing start-ups in China, Mobike and Ofo.
Stephen Davies, CEO of Javelin Wealth Management, weighs in on policies President Trump will focus on after he failed to repeal and replace Obamacare.